Evidence map›Paper›PMID 31264011›Full record

ArticleEuropean radiology2019

Cerebral sodium (

Melissa M Meyer, Alexander Schmidt, Justus Benrath, Simon Konstandin, Lothar R Pilz, Michael G Harrington, Johannes Budjan, Mathias Meyer, Lothar R Schad, Stefan O Schoenberg and 1 more

Open access · greenAbstract read
In one paragraph

Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Quantitative Sodium (Diagnostics (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Frontiers of Sodium MRI Revisited: From Cartilage to Brain Imaging.Journal of magnetic resonance imaging : JMRI · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Melissa M MeyerInstitute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. melissa.ong@gmx.de.ORCID http://orcid.org/0000-0002-2618-3971
Alexander SchmidtInstitute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Justus BenrathClinic for Anaesthesiology and Operative Intensive Care, University of Heidelberg, Mannheim, Germany.
Simon KonstandinMR-Imaging and Spectroscopy, Fraunhofer MEVIS, Bremen, Germany.
Lothar R PilzMedical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Michael G HarringtonHuntington Medical Research Institutes, Pasadena, CA, USA.
Johannes BudjanInstitute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Mathias MeyerInstitute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Lothar R SchadComputer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Stefan O SchoenbergInstitute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Stefan HanederDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
Heidelberg University · DEFraunhofer Institute for Digital Medicine · DEHuntington Medical Research Institutes · USUniversity Hospital Cologne · DE

Funding

Clinical and molecular pathophysiology of headacheR01NS043295 · NINDS · HUNTINGTON MEDICAL RESEARCH INSTITUTES · PI HARRINGTON, MICHAEL GORDON · 2003 to 2006
$1.4M
NINDS NIH HHS R01 NS043295
6 · The paper itself

Abstract

objectiveEvaluation of MRI-derived cerebral MATERIALS AND

methodsIn this case-control study, 24 female migraine patients (mean age, 34 ± 11 years) were enrolled after evaluation of standardized questionnaires. Half (n = 12) of the cohort suffered from migraine, the other half was impaired by both migraine and tension-type headaches (TTH). The combined patient cohort was matched to 12 healthy female controls (mean age, 34 ± 11 years). All participants underwent a cerebral

results

conclusionMRI-derived cerebral KEY POINTS: • Cerebral sodium MRI supports the theory of ionic imbalances and may aid in the challenging pathophysiologic understanding of migraine. • Case-control study shows significantly higher sodium concentrations in cerebrospinal fluid of migraineurs. • Cerebral sodium MRI may become a non-invasive imaging tool for drugs to modulate sodium, and hence migraine, on a molecular level, and influence patient management.

Indexed as

Phantoms, ImagingAdultCase-Control StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMigraine DisordersSodiumWhite MatterYoung AdultSodiumCerebrospinal fluidMagnetic resonance imagingMigraineSodium

Identifiers

PMID31264011
PMCPMC8018696
OpenAlexW2955181227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.